PAWR anticorps (C-Term)
Aperçu rapide pour PAWR anticorps (C-Term) (ABIN7185396)
Antigène
Voir toutes PAWR AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Réactivité croisée
- Humain, Souris, Rat
-
Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogène
- Synthesized peptide derived from the C-terminal region of Human PAR4.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB:1:500-1:2000, IHC:1:100-1:300, ELISA:1:10000,
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- PAWR (PRKC, Apoptosis, WT1, Regulator (PAWR))
-
Autre désignation
- PAWR
-
Sujet
- 2310001G03Rik antibody, PAR 4 antibody, PAR-4 antibody, Pawr antibody, PAWR_HUMAN antibody, PRKC Apoptosis WT1 Regulator antibody, PRKC apoptosis WT1 regulator protein antibody, Prostate apoptosis response 4 protein antibody, Prostate apoptosis response protein 4 antibody, prostate apoptosis response protein PAR-4 antibody, Transcriptional repressor Par-4-like protein PAWR antibody, Transcriptional repressor PAR4 antibody, WT1 Interacting Protein antibody
-
UniProt
- Q96IZ0
Antigène
-